日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression

法德拉西利(Fadraciclib)是一种 CDK2/CDK9 抑制剂,在胆道癌中显示出疗效,并且基于 MCL1 表达,与奥拉帕尼(olaparib)和 JQ1 具有协同作用的潜力。

Kim, Jae-Min; Nam, Ah-Rong; Oh, Kyoung-Seok; Bang, Ju-Hee; Jeong, Yoojin; Choo, Sea Young; Kim, Hyo Jung; Lee, Su In; Yoon, Jeesun; Kim, Tae-Yong; Oh, Do-Youn

Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

BOLD-100(一种 GRP78 抑制剂)在胰腺导管腺癌中的治疗潜力可通过 ATR 抑制而增强

Lee Su In, Nam Ah-Rong, Oh Kyoung-Seok, Kim Jae-Min, Bang Ju-Hee, Jeong Yoojin, Choo Sea Young, Kim Hyo Jung, Yoon Jeesun, Kim Tae-Yong, Oh Do-Youn

Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients

血清可溶性程序性死亡配体1的预后价值及其在晚期胃癌患者化疗期间的动态变化

Park, Woochan; Bang, Ju-Hee; Nam, Ah-Rong; Jin, Mei Hua; Seo, Hyerim; Kim, Jae-Min; Oh, Kyoung Seok; Kim, Tae-Yong; Oh, Do-Youn

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer

可溶性程序性死亡配体1及其在不可切除胰腺癌化疗期间动态变化的预后意义

Park, Hyunkyung; Bang, Ju-Hee; Nam, Ah-Rong; Eun Park, Ji; Hua Jin, Mei; Bang, Yung-Jue; Oh, Do-Youn

Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology

化疗期间可溶性程序性死亡配体1 (sPDL1) 的动态变化及其在癌症患者中的预后意义:免疫肿瘤学中的生物标志物开发

Ha, Hyerim; Bang, Ju-Hee; Nam, Ah-Rong; Park, Ji-Eun; Jin, Mei Hua; Bang, Yung-Jue; Oh, Do-Youn

The effect of abdominal drawing-in exercise and myofascial release on pain, flexibility, and balance of elderly females

腹部内收运动和肌筋膜放松对老年女性疼痛、柔韧性和平衡能力的影响

Yu, Seong Hun; Sim, Yong Hyeon; Kim, Myung Hoon; Bang, Ju Hee; Son, Kyung Hyun; Kim, Jae Woong; Kim, Hyun Jin

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

可溶性程序性死亡配体1 (sPDL1) 和中性粒细胞与淋巴细胞比值 (NLR) 可预测接受姑息化疗的晚期胆道癌患者的生存期

Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

达沙替尼治疗慢性粒细胞白血病引起的可逆性肺动脉高压

Hong, Ji Hyung; Lee, Sung-Eun; Choi, Soo Young; Kim, Soo-Hyun; Jang, Eun-Jung; Bang, Ju-Hee; Park, Jin Eok; Jeon, Hye-Rim; Oh, Yun Jeong; Yi, Jeong-Eun; Jung, Hae Ok; Youn, Ho Joong; Kim, Dong-Wook